REVIVED and STICH: Revascularization Versus Guideline Directed Medical Therapy in Ischemic Left Ventricular Systolic Dysfunction
Nov 29, 2022 | Rawan Amir, MBBS; Jeffrey C. Trost, MD; Roger S. Blumenthal, MD, FACC; William E. Boden, MD, FACC; Armin A. Zadeh, MD, PhD, MPH, FACC
Expert Analysis
Coronary artery disease (CAD) continues to be the leading cause of heart failure (HF) globally. The concept of salvaging hibernating myocardium in order to improve morbidity and mortality in patients with HF has been a topic of discussion for many...
Clinical Topics: Arrhythmias and Clinical EP, Cardiac Surgery, Cardiovascular Care Team, Dyslipidemia, Heart Failure and Cardiomyopathies, Invasive Cardiovascular Angiography and Intervention, Noninvasive Imaging, Atherosclerotic Disease (CAD/PAD), Implantable Devices, SCD/Ventricular Arrhythmias, Aortic Surgery, Cardiac Surgery and Arrhythmias, Cardiac Surgery and Heart Failure, Lipid Metabolism, Acute Heart Failure, Heart Failure and Cardiac Biomarkers, Interventions and Coronary Artery Disease, Interventions and Imaging, Computed Tomography, Magnetic Resonance Imaging, Nuclear Imaging
Keywords: Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors, Cardiomyopathies, Confidence Intervals, Constriction, Pathologic, Coronary Artery Bypass, Coronary Artery Disease, Coronary Vessels, Defibrillators, Cost of Illness, Digitalis, Dobutamine, Disease Progression, Follow-Up Studies, Glucose, Heart Failure, Hospitalization, Hydralazine, Hypoglycemic Agents, Ischemia, Incidence, Isosorbide Dinitrate, Magnetic Resonance Imaging, Life Style, Mineralocorticoid Receptor Antagonists, Morbidity, Myocardial Infarction, Neprilysin, Myocardium, Patient Selection, Percutaneous Coronary Intervention, Positron-Emission Tomography, Progression-Free Survival, Random Allocation, Prospective Studies, Receptors, Angiotensin, Stents, Risk Factors, Stroke Volume, Sodium, Symporters, Tomography, Emission-Computed, Single-Photon, Ventricular Function, Left, Ventricular Dysfunction